Hemab Therapeutics
biotechnology company developing prophylactic therapeutics for bleeding and thrombotic disorders
Hemab Therapeutics has raised €127M across 1 funding round from 9 investors, most recently a Series B round in Feb 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkhemab.com ↗
Total raised
€127M
€126,594,149
Funding rounds
1
Investors
9
distinct backers
Active since
2023-02
latest 2023-02
Funding by year
EUR raised per yearHemab Therapeutics — funding by year — interactive chart.
Data table
| Hemab Therapeutics — funding by year | |
|---|---|
| 2023 | €127M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-02-21 | Series B | €127M | Access Biotechnology,Avoro Capital Advisors,Deep Track Capital,HealthCap,Invus,Maj Invest Equity+3 more | View deal → |
Investors
9Related news
- Hemab Therapeutics Raises $135M in Series B Financingfinsmes.com · 2023-02
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData